erlotinib hydrochloride has been researched along with naphthalene in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (naphthalene) | Trials (naphthalene) | Recent Studies (post-2010) (naphthalene) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 2,650 | 5 | 919 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, Y; Tang, JF; Wang, XL; Yang, W; Yang, YS; Zhang, F; Zhang, YB; Zhong, WQ; Zhu, HL | 1 |
1 other study(ies) available for erlotinib hydrochloride and naphthalene
| Article | Year |
|---|---|
Design, modification and 3D QSAR studies of novel naphthalin-containing pyrazoline derivatives with/without thiourea skeleton as anticancer agents.
Topics: Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cell Survival; Crystallography, X-Ray; Drug Design; ErbB Receptors; Erlotinib Hydrochloride; Humans; MCF-7 Cells; Molecular Conformation; Molecular Docking Simulation; Naphthalenes; Protein Structure, Tertiary; Pyrazoles; Quantitative Structure-Activity Relationship; Quinazolines; Receptor, ErbB-2; Thiourea | 2013 |